Doximity (DOCS) Scheduled to Post Earnings on Thursday

Doximity (NASDAQ:DOCS) is scheduled to be announcing its earnings results after the market closes on Thursday, November 7th. Analysts expect the company to announce earnings of $0.26 per share for the quarter. Doximity has set its FY 2025 guidance at EPS and its Q2 2025 guidance at EPS.Investors that wish to listen to the company’s conference call can do so using this link.

Doximity (NASDAQ:DOCS) last released its earnings results on Thursday, August 8th. The company reported $0.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.16 by $0.06. Doximity had a return on equity of 19.26% and a net margin of 32.53%. The business had revenue of $126.68 million for the quarter, compared to the consensus estimate of $119.88 million. On average, analysts expect Doximity to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Doximity Stock Performance

DOCS opened at $41.98 on Thursday. The business’s 50-day simple moving average is $40.44 and its 200 day simple moving average is $32.15. The firm has a market capitalization of $7.79 billion, a PE ratio of 52.48, a PEG ratio of 5.29 and a beta of 1.29. Doximity has a 52-week low of $19.89 and a 52-week high of $44.88.

Analyst Ratings Changes

A number of brokerages recently weighed in on DOCS. Wells Fargo & Company downgraded shares of Doximity from an “equal weight” rating to an “underweight” rating and lowered their target price for the stock from $27.00 to $19.00 in a report on Thursday, July 18th. Evercore ISI raised their target price on shares of Doximity from $34.00 to $45.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Truist Financial reiterated a “hold” rating and set a $35.00 price target (up previously from $31.00) on shares of Doximity in a report on Wednesday, August 14th. Barclays upgraded Doximity from an “equal weight” rating to an “overweight” rating and upped their price objective for the company from $35.00 to $52.00 in a research note on Tuesday, October 15th. Finally, Canaccord Genuity Group lifted their target price on Doximity from $37.00 to $40.00 and gave the stock a “buy” rating in a research note on Tuesday, August 20th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $36.42.

Insider Transactions at Doximity

In related news, CFO Anna Bryson sold 30,000 shares of the firm’s stock in a transaction dated Friday, August 9th. The shares were sold at an average price of $35.00, for a total transaction of $1,050,000.00. Following the transaction, the chief financial officer now directly owns 309,627 shares of the company’s stock, valued at approximately $10,836,945. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, CFO Anna Bryson sold 30,000 shares of the business’s stock in a transaction that occurred on Friday, August 9th. The stock was sold at an average price of $35.00, for a total value of $1,050,000.00. Following the completion of the sale, the chief financial officer now directly owns 309,627 shares in the company, valued at approximately $10,836,945. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Watkin Phoebe L. Yang sold 1,011 shares of the firm’s stock in a transaction on Monday, August 5th. The stock was sold at an average price of $25.54, for a total value of $25,820.94. Following the transaction, the director now owns 11,258 shares in the company, valued at approximately $287,529.32. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 37.40% of the company’s stock.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.